文献速递免疫规划妇幼与学校卫生

呼吸道合胞病毒(RSV)预防:荷兰准父母认知与接种意愿调查

Respiratory syncytial virus (RSV) prevention: Perception and willingness of expectant parents in the Netherlands.
PubMed 文献 · Vaccine · 2024-11-30

研究在荷兰对1001名孕妇及其伴侣开展横断面调查,评估其对母体RSV疫苗和新生儿RSV免疫预防的接受度。87%受访者表示会(可能)接受两种策略,但多数人(孕妇75.3%、伴侣71.6%)在可选时更倾向母体接种而非婴儿被动免疫。

要点

  • 87%受访者表示会(可能)接受母体疫苗和新生儿免疫两种RSV预防策略。
  • 在有选择时,75.3%孕妇和71.6%伴侣更倾向母体接种而非婴儿被动免疫。
  • 对RSV严重性的既往经历、新生儿接种意愿及父母疫苗接种状态与积极态度相关。

核心结论

  • 多数参与者会接受两种RSV预防策略,但多数人尤其已有其他孩子的父母因担忧婴儿安全和知晓RSV严重性而更倾向母体接种。

研究设计与样本

  • 在荷兰通过医护人员、社交媒体平台和9个月博览会招募孕妇及其伴侣开展横断面调查。

主要发现

  • 共1001名孕妇(平均年龄31.1岁)及其伴侣(平均年龄33.2岁)完成调查,平均孕24周,54.6%尚无其他孩子。
  • 95.2%女性为荷兰出生,68.3%女性完成高等教育,93.9%伴侣打算为新生儿接种疫苗。
  • 87%受访者表示会(可能)接受母体疫苗和新生儿免疫两种策略。
  • 在有选择时,75.3%孕妇和71.6%伴侣更倾向母体接种而非婴儿被动免疫。
  • 对两种方法的积极态度与既往RSV严重性经历、新生儿接种意愿及父母童年和当前孕期疫苗接种状态相关。

关键数值与推荐

  • 多数受访者认为为孩子提供最佳保护和了解RSV是接受RSV预防的重要因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of infant respiratory disease. Recent approval of preventive measures like a long-acting monoclonal antibody and a maternal vaccine signals a potential shift in early-life RSV infection control. However, success hinges on acceptance. METHODS: We conducted a cross-sectional survey among pregnant women and partners in the Netherlands, recruited via healthcare professionals, social media platforms, and the 9-Months Fair. The survey assessed willingness and motivation for maternal RSV vaccination and neonatal RSV immunization, including strategy preferences and informational needs. RESULTS: In total 1001 pregnant women (mean age: 31.1 years) and their partners (mean age: 33.2 years) completed the survey. On average, they were 24 weeks pregnant at the time, and 54.6 % had no other children yet. The majority was Dutch-born (95.2 % of women); with 68.3 % of women having completed higher education and with overall strong pro-vaccination attitudes (93.9 % of partners intended to vaccinate their expected newborn). The overall acceptability to vaccination and immunization was high, with 87 % of respondents indicating they would (likely) accept both strategies. A positive attitude towards both methods was associated with previous experience with severity of RSV, intention to vaccinate the newborn and parental vaccination status during childhood and current pregnancy. When the choice was given, the majority of participants, in particular those with children and the intention to breastfeed, favoured maternal vaccination over passive immunization of infants (75.3 % of the pregnant and 71.6 % of the partners). A majority of the respondents cited optimal protection for the child and knowledge of RSV as important factors for accepting RSV prophylaxis. CONCLUSIONS: While most participants would accept both strategies for RSV protection of their infant, a majority, especially those with other children, favoured maternal vaccination, due to concerns about infant safety and awareness of RSV severity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Harteveld LM, van Leeuwen LM, Euser SM, et al. Respiratory syncytial virus (RSV) prevention: Perception and willingness of expectant parents in the Netherlands. Vaccine. 2024. PMID: 39616950. doi:10.1016/j.vaccine.2024.126541

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。